250 related articles for article (PubMed ID: 23679136)
21. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
Chen SC; Marriott D; Playford EG; Nguyen Q; Ellis D; Meyer W; Sorrell TC; Slavin M;
Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
[TBL] [Abstract][Full Text] [Related]
22. [Rapid identification and susceptibility to killer toxins of yeasts isolated from non-systemic mycoses].
Sangorrín MP; Lopes CA; Rivero A; Caballero AC
Rev Argent Microbiol; 2007; 39(4):230-6. PubMed ID: 18390160
[TBL] [Abstract][Full Text] [Related]
23. Multicenter evaluation of Candida QuickFISH BC for identification of Candida species directly from blood culture bottles.
Abdelhamed AM; Zhang SX; Watkins T; Morgan MA; Wu F; Buckner RJ; Fuller DD; Davis TE; Salimnia H; Fairfax MR; Lephart PR; Poulter MD; Regi SB; Jacobs MR
J Clin Microbiol; 2015 May; 53(5):1672-6. PubMed ID: 25762766
[TBL] [Abstract][Full Text] [Related]
24. DNA pyrosequencing-based identification of pathogenic Candida species by using the internal transcribed spacer 2 region.
Boyanton BL; Luna RA; Fasciano LR; Menne KG; Versalovic J
Arch Pathol Lab Med; 2008 Apr; 132(4):667-74. PubMed ID: 18384218
[TBL] [Abstract][Full Text] [Related]
25. Identification of Candida dubliniensis in a diagnostic microbiology laboratory.
Momani OM; Qaddoomi A
East Mediterr Health J; 2005 May; 11(3):366-71. PubMed ID: 16602455
[TBL] [Abstract][Full Text] [Related]
26. Rapid and accurate identification of isolates of Candida species by melting peak and melting curve analysis of the internally transcribed spacer region 2 fragment (ITS2-MCA).
Decat E; Van Mechelen E; Saerens B; Vermeulen SJ; Boekhout T; De Blaiser S; Vaneechoutte M; Deschaght P
Res Microbiol; 2013; 164(2):110-7. PubMed ID: 23142490
[TBL] [Abstract][Full Text] [Related]
27. Candida dubliniensis, a new fungal pathogen.
Gutiérrez J; Morales P; González MA; Quindós G
J Basic Microbiol; 2002; 42(3):207-27. PubMed ID: 12111748
[TBL] [Abstract][Full Text] [Related]
28. Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida.
Hospenthal DR; Beckius ML; Floyd KL; Horvath LL; Murray CK
Ann Clin Microbiol Antimicrob; 2006 Jan; 5():1. PubMed ID: 16390552
[TBL] [Abstract][Full Text] [Related]
29. Study of molecular epidemiology of candidiasis in portugal by PCR fingerprinting of Candida clinical isolates.
Correia A; Sampaio P; Almeida J; Pais C
J Clin Microbiol; 2004 Dec; 42(12):5899-903. PubMed ID: 15583336
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of the significance of molecular methods in the diagnosis of invasive fungal infections: comparison with conventional methods].
Susever S; Yeğenoğlu Y
Mikrobiyol Bul; 2011 Apr; 45(2):325-35. PubMed ID: 21644076
[TBL] [Abstract][Full Text] [Related]
31. Use of CHROMagar medium in the differentiation of Candida species: is it cost-effective in developing countries?
Iyampillai T; Michael JS; Mathai E; Mathews MS
Ann Trop Med Parasitol; 2004 Apr; 98(3):279-82. PubMed ID: 15119973
[TBL] [Abstract][Full Text] [Related]
32. Rapid, simple, and low-cost identification of Candida species using high-resolution melting analysis.
Arancia S; Sandini S; De Bernardis F; Fortini D
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):283-5. PubMed ID: 21353953
[TBL] [Abstract][Full Text] [Related]
33. Comparison of phenotypic methods for the identification of Candida dubliniensis.
Pasligh J; Radecke C; Fleischhacker M; Ruhnke M
J Microbiol Immunol Infect; 2010 Apr; 43(2):147-54. PubMed ID: 20457432
[TBL] [Abstract][Full Text] [Related]
34. Multiplex PCR identification of eight clinically relevant Candida species.
Carvalho A; Costa-De-Oliveira S; Martins ML; Pina-Vaz C; Rodrigues AG; Ludovico P; Rodrigues F
Med Mycol; 2007 Nov; 45(7):619-27. PubMed ID: 17885953
[TBL] [Abstract][Full Text] [Related]
35. PCR-AGE, automated and manual methods to identify Candida strains from veterinary sources: a comparative approach.
Brito EH; Brilhante RS; Cordeiro RA; Sidrim JJ; Fontenelle RO; Melo LM; Albuquerque ES; Rocha MF
Vet Microbiol; 2009 Nov; 139(3-4):318-22. PubMed ID: 19592181
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of different methods for the identification of Candida species isolated from clinical specimens].
Cetinkaya Z; Altindiş M; Aktepe OC; Karabiçak N
Mikrobiyol Bul; 2003 Oct; 37(4):269-76. PubMed ID: 14748264
[TBL] [Abstract][Full Text] [Related]
37. Identification of Candida species using PCR-RFLP in cancer patients in Iran.
Shokohi T; Hashemi Soteh MB; Saltanat Pouri Z; Hedayati MT; Mayahi S
Indian J Med Microbiol; 2010; 28(2):147-51. PubMed ID: 20404462
[TBL] [Abstract][Full Text] [Related]
38. Current methods for identifying clinically important cryptic Candida species.
Criseo G; Scordino F; Romeo O
J Microbiol Methods; 2015 Apr; 111():50-6. PubMed ID: 25659326
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Vitek 2 for identification of yeasts in the clinical laboratory.
Meurman O; Koskensalo A; Rantakokko-Jalava K
Clin Microbiol Infect; 2006 Jun; 12(6):591-3. PubMed ID: 16700713
[TBL] [Abstract][Full Text] [Related]
40. [Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry vs conventional methods in the identification of Candida non-albicans].
Martínez-Lamas L; Pérez del Molino ML; Pardo F; Varela E; Regueiro BJ
Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):568-72. PubMed ID: 21782293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
